FDA Adverse Event Injury Summary report: N

RESONANCE URETERAL STENT METALLIC STENT AND POSITIONER

MDR report key: 10507271 · Received September 9, 2020

Report

Report Number
3005580113-2020-00411
Event Type
Injury
Date Received
September 9, 2020
Date of Event
June 13, 2019
Report Date
September 9, 2020
Manufacturer
COOK IRELAND LTD
Product Code
FAD
Adverse Event
Yes
Product Problem
Yes
Report Source
Distributor report
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 1

FAD STENT, URETERAL.

Description of Event or Problem · 1

ACCORDING TO THE JOURNAL ARTICLE: "NAVETTA, 2019 ¿TANDEM RESONANCE METALLIC DOUBLE-J URETERAL STENTS IN A SINGLE URETER FOR SALVAGE MANAGEMENT OF CHRONIC URETERAL OBSTRUCTION¿. "WE REPORT OUR EXPERIENCE PLACING TANDEM RESONANCE STENTS (TRS) IN A SINGLE URETER OF PATIENTS WHO FAILED MANAGEMENT WITH A SINGLE RESONANCE STENT. WE REPORT OUR EXPERIENCE IN A SMALL SERIES OF PATIENTS WHOSE URETERAL OBSTRUCTION WAS MANAGED IN THIS FASHION DUE TO FAILURE OF A SINGLE RESONANCE STENT AND DECLINED PLACEMENT OF A PCN." "HYDRONEPHROSIS ON FOLLOW-UP IMAGING AND RENAL FAILURE WERE THE MOST COMMON REASONS FOR FAILURE OF A SINGLE RESONANCE STENT, WITH RATES OF 100% AND 71.4%, RESPECTIVELY 4 PATIENTS WITH A MEDIAN AGE OF 62 YEARS WERE MANAGED WITH TRS." PLEASE ALSO NOTE, ALTHOUGH WE CANNOT CONFIRM THE EXACT RPN OF THE RESONANCE METALLIC DOUBLE-J URETERAL STENTS USED IT HAD THE POTENTIAL TO BE ANYONE IF THE FOLLOWING: RMS-060012-R, RMS-060014-R, RMS-060016-R, RMS-060018-R, RMS-060020-R, RMS-060022-R, RMS-060024-R, RMS-060026-R, RMS-060028-R, RMS-060030-R. AS CONFIRMED BY CLINICAL ADVISOR, RENAL FAILURE WAS A CASCADING EFFECT OF THE HYDRONEPHROSIS AND BOTH ADVERSE EVENTS ARE RELATED. THIS FILE IS CREATED TO CAPTURE 4 CASES OF HYDROPNEPHROSIS AND RENAL FAILURE DUE TO FAILURE OF SINGLE RMS STENT.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
972866 RESONANCE URETERAL STENT METALLIC STENT AND POSITIONER FAD COOK IRELAND LTD UNKNOWN

Patients

Seq Age Sex Outcome Treatment
1 Required Intervention